Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Polyinosinic-polycytidylic acid treatment of neuropathy.

Engel WK, Cuneo RA, Levy HB.

Lancet. 1978 Mar 4;1(8062):503-4. No abstract available.

PMID:
76048
2.

Treatment of advanced ovarian cancer with polyinosinic-polycytidylic lysine carboxymethylcellulose (poly(ICLC)).

Rettenmaier MA, Berman ML, DiSaia PJ.

Gynecol Oncol. 1986 Jul;24(3):359-61.

PMID:
3721308
3.

[Effect of a modified polyinosinic acid--polycytidylic acid complex against herpes simplex keratitis in monkeys (author's transl)].

Teranishi H.

Nippon Ganka Gakkai Zasshi. 1980 Sep 10;84(9):1198-204. Japanese. No abstract available.

PMID:
7223554
4.

Poly ICLC inhibits Plasmodium cynomolgi B malaria infection in rhesus monkeys.

Puri SK, Dutta GP, Levy HB, Maheshwari RK.

J Interferon Cytokine Res. 1996 Jan;16(1):49-52.

PMID:
8640451
5.

Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma.

Okada H, Kalinski P, Ueda R, Hoji A, Kohanbash G, Donegan TE, Mintz AH, Engh JA, Bartlett DL, Brown CK, Zeh H, Holtzman MP, Reinhart TA, Whiteside TL, Butterfield LH, Hamilton RL, Potter DM, Pollack IF, Salazar AM, Lieberman FS.

J Clin Oncol. 2011 Jan 20;29(3):330-6. doi: 10.1200/JCO.2010.30.7744. Epub 2010 Dec 13.

6.

Evaluation of polyinosinic-polycytidylic and poly-L-lysine in metastatic breast cancer.

Theriault RL, Hortobagyi GN, Buzdar AU, Levy HB, Hersh EM.

Cancer Treat Rep. 1986 Nov;70(11):1341-2. No abstract available.

PMID:
3768878
7.

Poly(I:C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs.

Ammi R, De Waele J, Willemen Y, Van Brussel I, Schrijvers DM, Lion E, Smits EL.

Pharmacol Ther. 2015 Feb;146:120-31. doi: 10.1016/j.pharmthera.2014.09.010. Epub 2014 Oct 2. Review.

PMID:
25281915
8.

A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas.

Butowski N, Lamborn KR, Lee BL, Prados MD, Cloughesy T, DeAngelis LM, Abrey L, Fink K, Lieberman F, Mehta M, Ian Robins H, Junck L, Salazar AM, Chang SM.

J Neurooncol. 2009 Jan;91(2):183-9. doi: 10.1007/s11060-008-9705-3. Epub 2008 Oct 11.

9.

Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-L-lysine solubilized by carboxymethylcellulose.

Talmadge JE, Adams J, Phillips H, Collins M, Lenz B, Schneider M, Chirigos M.

Cancer Res. 1985 Mar;45(3):1066-72.

11.

Studies on hepatic oxidative stress and antioxidant defence system during chloroquine/poly ICLC treatment of Plasmodium yoelii nigeriensis infected mice.

Siddiqi NJ, Puri SK, Dutta GP, Maheshwari RK, Pandey VC.

Mol Cell Biochem. 1999 Apr;194(1-2):179-83.

PMID:
10391138
12.

Therapeutic in situ autovaccination against solid cancers with intratumoral poly-ICLC: case report, hypothesis, and clinical trial.

Salazar AM, Erlich RB, Mark A, Bhardwaj N, Herberman RB.

Cancer Immunol Res. 2014 Aug;2(8):720-4. doi: 10.1158/2326-6066.CIR-14-0024. Epub 2014 May 6.

13.

Pharmacokinetic and therapeutic activity of polyinosinic-polycytidylic acid stabilized with poly-L-lysine in carboxymethylcellulose [poly(I,C)-LC].

Chirigos MA, Schlick E, Ruffmann R, Budzynski W, Sinibaldi P, Gruys E.

J Biol Response Mod. 1985 Dec;4(6):621-7.

PMID:
4087033
14.

Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects.

Ewel CH, Urba WJ, Kopp WC, Smith JW 2nd, Steis RG, Rossio JL, Longo DL, Jones MJ, Alvord WG, Pinsky CM, et al.

Cancer Res. 1992 Jun 1;52(11):3005-10.

15.

Phase I trials of poly(I,C) complexes in advanced cancer.

Krown SE, Kerr D, Stewart WE 2nd, Field AK, Oettgen HF.

J Biol Response Mod. 1985 Dec;4(6):640-9.

PMID:
2418162
17.
18.

Effect of tumor burden and route of administration on the immunotherapeutic properties of polyinosinic-polycytidylic acid stabilized with poly-L-lysine in carboxymethyl cellulose [Poly(I,C)-LC].

Black PL, Hartmann D, Pennington R, Phillips H, Schneider M, Tribble HR, Talmadge JE.

Int J Immunopharmacol. 1992 Nov;14(8):1341-53.

PMID:
1464467
19.

Liver enzyme abnormalities after poly ICLC infusions.

Hess WA, Bever CT, McFarlin DE.

Cancer Treat Rep. 1985 Nov;69(11):1342. No abstract available.

PMID:
2418967
20.

The primary nurse as a care giver in a neurology research setting.

Graham OC, Carico J.

J Neurosurg Nurs. 1985 Aug;17(4):260-8.

PMID:
3849568
Items per page

Supplemental Content

Write to the Help Desk